DK3197487T3 - Vaccination af immunsvækkede individer - Google Patents
Vaccination af immunsvækkede individer Download PDFInfo
- Publication number
- DK3197487T3 DK3197487T3 DK15781436.9T DK15781436T DK3197487T3 DK 3197487 T3 DK3197487 T3 DK 3197487T3 DK 15781436 T DK15781436 T DK 15781436T DK 3197487 T3 DK3197487 T3 DK 3197487T3
- Authority
- DK
- Denmark
- Prior art keywords
- vaccination
- immune compromised
- compromised individuals
- individuals
- immune
- Prior art date
Links
- 230000001010 compromised effect Effects 0.000 title 1
- 238000002255 vaccination Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462056019P | 2014-09-26 | 2014-09-26 | |
| EP14192174 | 2014-11-06 | ||
| US201562149351P | 2015-04-17 | 2015-04-17 | |
| PCT/IB2015/057388 WO2016046799A1 (en) | 2014-09-26 | 2015-09-25 | Vaccination of immunocompromised subjects |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3197487T3 true DK3197487T3 (da) | 2022-09-05 |
Family
ID=80116043
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK15781436.9T DK3197487T3 (da) | 2014-09-26 | 2015-09-25 | Vaccination af immunsvækkede individer |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US20240342267A1 (da) |
| EP (1) | EP4144369A1 (da) |
| JP (1) | JP2022009403A (da) |
| KR (1) | KR20230154072A (da) |
| DK (1) | DK3197487T3 (da) |
| ES (1) | ES2927797T3 (da) |
| HU (1) | HUE060456T2 (da) |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI21352A (sl) | 2001-01-23 | 2004-06-30 | Aventis Pasteur | Multivalentno meningokokno cepivo iz konjugata polisaharida-proteina |
| KR101074175B1 (ko) | 2002-01-15 | 2011-10-14 | 사노피 파스테르 바이오로직스 씨오 | 플라비바이러스 백신 |
| US20040259224A1 (en) | 2002-05-31 | 2004-12-23 | Farshad Guirakhoo | Tetravalent Dengue vaccines |
| AR054020A1 (es) | 2005-03-23 | 2007-05-30 | Glaxosmithkline Biolog Sa | Nuevo uso |
| JP5227172B2 (ja) | 2005-08-10 | 2013-07-03 | サノフィ パスツール バイオロジクス リミテッド ライアビリティ カンパニー | デングウイルス感染に対するワクチン接種 |
| CA2650980A1 (en) * | 2006-05-04 | 2007-11-15 | Patrick T. Prendergast | Statins for the treatment of viral influenza infections |
| FR2909286B1 (fr) | 2006-12-01 | 2012-06-08 | Sanofi Pasteur | Methode d'immunisation contre les 4 serotypes de la dengue |
| EP2143440A1 (fr) | 2008-07-09 | 2010-01-13 | Sanofi Pasteur | Agent stabilisant et composition vaccinale comprenant un ou plusieurs flavivirus vivants atténués |
| EP3173097A3 (en) | 2009-02-10 | 2017-07-12 | Seqirus UK Limited | Influenza vaccines with reduced amounts of squalene |
| CN104688687A (zh) | 2009-12-03 | 2015-06-10 | 诺华股份有限公司 | 疫苗佐剂制备中的亲水过滤 |
| RS52565B (sr) | 2009-12-03 | 2013-04-30 | Novartis Ag | Metod interakcije i komore sa povratnim pritiskom za mikrofluidizaciju |
| EP2506834B1 (en) | 2009-12-03 | 2016-03-02 | Novartis AG | Circulation of components during homogenization and microfluidization of emulsions |
| EP2353609A1 (en) | 2010-02-04 | 2011-08-10 | Sanofi Pasteur | Immunization compositions and methods |
| MX374963B (es) | 2011-04-29 | 2025-03-06 | Selecta Biosciences Inc | Nanoportadores sintéticos tolerogénicos para reducir las respuestas de anticuerpos. |
| JP2014040396A (ja) | 2012-08-23 | 2014-03-06 | Chemo-Sero-Therapeutic Research Institute | 脂質異常症治療薬を含有するアジュバント組成物 |
| BR112015012515B1 (pt) | 2012-11-30 | 2023-04-11 | Sanofi Pasteur | Uso de antígenos, construções de ácido nucleico ou vetores virais capazes de expressar uma partícula do tipo vírus (vlp) da dengue e de uma vacina contra sarampo, uma vacina contra caxumba e uma vacina contra rubéola |
| EP2742952A1 (en) * | 2012-12-17 | 2014-06-18 | Eurocine Vaccines AB | Influenza vaccine composition |
| AU2015323334B2 (en) | 2014-09-26 | 2021-02-25 | Seqirus UK Limited | Vaccination of immunocompromised subjects |
-
2015
- 2015-09-25 DK DK15781436.9T patent/DK3197487T3/da active
- 2015-09-25 KR KR1020237034247A patent/KR20230154072A/ko not_active Ceased
- 2015-09-25 ES ES15781436T patent/ES2927797T3/es active Active
- 2015-09-25 EP EP22188224.4A patent/EP4144369A1/en not_active Withdrawn
- 2015-09-25 HU HUE15781436A patent/HUE060456T2/hu unknown
-
2021
- 2021-10-22 JP JP2021172983A patent/JP2022009403A/ja active Pending
-
2023
- 2023-12-22 US US18/394,260 patent/US20240342267A1/en not_active Abandoned
-
2025
- 2025-04-18 US US19/182,766 patent/US12558412B2/en active Active
- 2025-04-18 US US19/182,727 patent/US20250269008A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20250269008A1 (en) | 2025-08-28 |
| US12558412B2 (en) | 2026-02-24 |
| ES2927797T3 (es) | 2022-11-11 |
| US20240342267A1 (en) | 2024-10-17 |
| US20250242011A1 (en) | 2025-07-31 |
| JP2022009403A (ja) | 2022-01-14 |
| KR20230154072A (ko) | 2023-11-07 |
| HUE060456T2 (hu) | 2023-03-28 |
| EP4144369A1 (en) | 2023-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL284348A (en) | Hiv pre-immunization and immunotherapy | |
| DK3262071T3 (da) | Fremgangsmåde til anvendelse af anti-CD79b-immunkonjugater | |
| DK3393510T3 (da) | Zikavirusvaccine | |
| DK3137169T3 (da) | Hæmmere af lysin-specifik demethylase-1 | |
| DK3851537T3 (da) | Behandling af hyperbilirubinæmi | |
| IL249643A0 (en) | Ophthalmic composition | |
| CL2016002252A1 (es) | Anticuerpos anti-egfrviii y usos de los mismos | |
| DK3611262T3 (da) | Fremgangsmåder til sekvensering af immunrepertoire | |
| DK3180331T3 (da) | Polymorfer af selinexor | |
| DK3132009T3 (da) | Fremgangsmåde | |
| IL248223A0 (en) | Vaccine compositions | |
| DK3237621T3 (da) | Varianter af human alpha-galactosidase | |
| DK3191498T3 (da) | Fremgangsmåde til fremstilling af 2'-o-fucosyllactose | |
| DK3137449T3 (da) | Fremgangsmåder til fremstilling af substituerede cycloseriner | |
| DK3228312T3 (da) | Immunregulator | |
| DK3418273T3 (da) | Derivater af flavagliner | |
| DK2897382T3 (da) | Forbedring af binaural kilde | |
| DK3511000T3 (da) | Krystallinsk form x2 af grapiprant | |
| LT3122378T (lt) | Mutantų stafilokokiniai antigenai | |
| DK3201323T3 (da) | Modificering af bakteriofag | |
| HUE047158T2 (hu) | Optikai pirométer | |
| ES1103231Y (es) | Conjunto de asientos infantiles | |
| FR3024647B1 (fr) | Transat de puericulture | |
| FR3022129B1 (fr) | Baignoire de puericulture | |
| DK3200783T3 (da) | Behandling af erytromelalgi |